Researchers analyze 2.2 million genomes to show that addiction risk is primarily driven by broad genes affecting brain wiring and impulse control, not drug-specific traits.
Most of the genetic risk for developing a substance use disorder comes from genes that broadly affect how our brains process ...
Tobacco-related disorders include tobacco use disorder and tobacco withdrawal. Tobacco and tobacco-based products contain many harmful substances, including nicotine, a highly addictive chemical that ...
Variants in a nicotine receptor gene are associated with a lower likelihood of heavy smoking, according to a study published in Nature Communications. The findings are based on data from populations ...
MedPage Today on MSN
Cannabinoids for mental, substance use disorders 'rarely justified,' study suggests
Cannabis compounds may reduce symptoms for some disorders, but evidence quality is low ...
There was some evidence that cannabinoids can reduce symptoms of cannabis use disorder, insomnia, tic or Tourette's syndrome, and autism spectrum disorder, but the quality of this evidence was ...
Please provide your email address to receive an email when new articles are posted on . Physicians are busy and do not have much time for ongoing medical education. Trainees and attending physicians ...
Psychedelic therapy is a promising approach for tackling tobacco addiction, early results of a pilot clinical trial show in which psilocybin outperformed nicotine patches in helping smokers quit.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results